EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective

Mirjam Wolfschlag iD, Elena Espa iD, Kevin Oliveira Hauer iD, Jonathan Timpka, Ruben Smith, Per Odin, Maria Angela Cenci iD, Anders Håkansson iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70264 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Mirjam Wolfschlag und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Addiction Research Unit, Psychiatry, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Compulsive Behavior, Dopamine Agonists, Parkinson Disease, Disruptive, Impulse Control, and Conduct Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Svenska Spel AB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dopaminergic medication used in disorders like Parkinson's disease (PD) and restless legs syndrome can cause impulsive‐compulsive behaviour (ICB), often with strong negative effects on patients' quality of life. This narrative review presents translational evidence on iatrogenic ICB, taking findings from epidemiological, clinical, neuroimaging and preclinical studies into consideration. Epidemiological and clinical studies find dopamine agonists with high D2/3‐selectivity to be most strongly linked to ICB. Their effect on ICB has often been shown to be dose‐dependent, but the impact of combining different dopaminergic drugs or applying extended‐release formulations is less clear. Intervention studies support tapering or replacing dopamine agonists for ICB reduction, whereas no efficacious pharmacotherapy has been identified for ICB treatment specifically. Adequate animal models for mimicking different types of ICB are available, and point, in line with human neuroimaging studies, towards an involvement of striatum and prefrontal cortex in iatrogenic ICB. Overall, complementary research designs have led to profound evidence regarding the occurrence of ICB in PD and establishing methods transferable to other, less‐studied patient populations. A combined approach integrating insights from human studies and animal models could contribute to developing dopaminergic drugs with lower ICB risk but also specific pharmacotherapies for impulsivity or compulsivity in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Compulsive BehaviorDopamine AgonistsParkinson DiseaseDisruptive, Impulse Control, and Conduct DisordersImpulsive BehaviorDopamine AgentsHumansAnimalsRestless Legs SyndromeDisease Models, AnimalTranslational Research, BiomedicalQuality of Life

Stichwörter der Autor:innen

Parkinson's diseasedopamine agonistimpulse control disorderimpulsive‐compulsive behaviourrestless legs syndrome

Substanzen

Dopamine AgonistsDopamine Agents

Autor:innen und Institutionen

  • Clinical Addiction Research Unit, Psychiatry, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.
  • Region Skåne, Malmö Addiction Center, Skåne University Hospital, Malmö, Sweden.
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Faculty of Medicine, Lund University, Lund, Sweden.
  • Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Lund, Sweden.
  • Region Skåne, Memory Clinic, Skåne University Hospital, Malmö, Sweden.
  • Division of Neurology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.

ORCID-Profile: Mirjam Wolfschlag, Elena Espa, Kevin Oliveira Hauer, Maria Angela Cenci, Anders Håkansson

Förderung

  • Research Council of Svenska Spel AB

Zitieren

APA

Wolfschlag, M., Espa, E., Hauer, K. O., Timpka, J., Smith, R., Odin, P., Cenci, M. A., & Håkansson, A. (2026). The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70264

Vancouver

Wolfschlag M, Espa E, Hauer KO, Timpka J, Smith R, Odin P, et al. The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70264

BibTeX
@article{Wolfschlag2026,
  author = {Wolfschlag, Mirjam and Espa, Elena and Hauer, Kevin Oliveira and Timpka, Jonathan and Smith, Ruben and Odin, Per and Cenci, Maria Angela and Håkansson, Anders},
  title = {The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70264}
}
Kostenlos starten →